[Streptococcus pyogenes and Mycoplasma pneumoniae: pulmonary coinfection or serologic artefact?]

Philippe Corne1, Thibaut Grieu, Jonquet Olivier

  • 1Service de réanimation médicale-assistance respiratoire, Hôpital Gui de Chauliac, 80, av. Augustin Fliche, 34295 Montpellier 5. p-corne@chu-montpellier.fr

Presse Medicale (Paris, France : 1983)
|August 16, 2005
PubMed
Abstract

Insights

Interpreting Mycoplasma pneumoniae seroconversion requires careful consideration in patients with Streptococcus pyogenes pneumonia. A coinfection or a nonspecific antibody response are potential explanations.

Area of Science:

  • Infectious Diseases
  • Clinical Microbiology
  • Immunology

Background:

  • Pneumonia diagnosis can be complicated by co-occurring infections.
  • Understanding serological markers for atypical pneumonia is crucial.

Observation:

  • A case of a 21-year-old male with cerebral palsy presented with acute pneumonia.
  • Bronchoalveolar lavage identified Streptococcus pyogenes.
  • Serological tests indicated Mycoplasma pneumoniae infection.

Findings:

  • The patient showed positive seroconversion for Mycoplasma pneumoniae alongside Streptococcus pyogenes.
  • Elevated antistreptolysin O antibodies confirmed the S. pyogenes infection.

Implications:

  • This case highlights the diagnostic challenge in differentiating coinfection from nonspecific antibody responses.
  • Further investigation is needed to clarify the role of Mycoplasma pneumoniae in severe Streptococcus pyogenes pneumonia.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...